| Variation name (cDNA level) | Variation name (protein level) | Variation status | Variation class |
| c.IVS41-2A>C (c.5225-2A>C) | Heterozygous | Mutation |
| wt codon | wt aa | mutant codon | mutant aa | mutational event | mutation type |
| GAT | Asp | spl-2 | Spl. | A->C | Tv |
| Structure | Key Residue (HCD) | Pyrimidin doublet | CpG |
| TGFBP#05 |
| At the mRNA level | On restriction map |
| Not tested on cDNA | New restriction site(s): none Lost restriction site(s): none |
| Impact on splicing | ||||||||||
| Splice site type | Wild type sequence | CV | Mutant type sequence | CV | Variation (%) | |||||
| taatcattgcagAT |
| taatcattgccgAT |
| -33.7 % | ||||||
| Sample ID | Patient status | Gender | Transmission | Age of onset | Age of death | Geographic origin |
| BEL01GHE F0168 I01 | Proband | NA | NA | BELGIUM |
| Phenotypic group | Disease |
| NA | Unknown |
| Symptom |
| Reference ID | Reference |
| 122 | Unpublished data |